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ttp://dx.doi.org/10.1016/j.ajpath.2014.02.007To conditionally inactivate genes in the retinal pigment epithelium (RPE) transgenic mouse strains have
been developed, in which Cre recombinase (Cre) expression is driven by an RPE-speciﬁc gene promoter.
The RPE is a quiescent epithelium, and continuous expression of Cre could affect its function. Here, we
tested the hypothesis that continuous postnatal Cre expression in the RPE may lead to cellular ab-
normalities, which may depend on both age and Cre gene dosage. We therefore examined the eyes of
homozygous and heterozygous VMD2-Cre mice at various ages. In VMD2-Cre heterozygous mice variable
progressive age-dependent RPE abnormalities were noticed, including attenuation of phalloidin and
cytoplasmic active b-catenin staining, reduced cell size, and loss of the typical honeycomb pattern of
RPE morphology in those RPE cells that stained for Cre. These morphological RPE abnormalities were not
noticed in Cre-negative RPE cells in VMD2-Cre or age-matched control mice. In addition, an abnormal
number and morphology of cell nuclei were noticed in a subset of Cre-expressing RPE cells in aged
heterozygous VMD2-Cre mice, whereas more severe nuclear abnormalities were observed already in
young homozygous VMD2-Cre mice. Thus, continuous postnatal expression of Cre causes abnormalities
in the RPE in an age- and Cre gene dosage-dependent manner, which needs to be considered in the
interpretation of gene targeting studies in the RPE. (Am J Pathol 2014, 184: 1660e1667; http://
dx.doi.org/10.1016/j.ajpath.2014.02.007)This work was supported by NIH National Eye Institute grant
R01-EY019297 (A.G.M.).
Disclosures: None declared.The retinal pigment epithelium (RPE) is a nonregenerative
single layer epithelium in the adult eye that is essential for
the visual cycle and photoreceptor function.1 Degenerative
changes in the RPE affect retinal function and cause several
ocular diseases. The fact that this epithelium does not
continuously regenerate postnatally could make this
epithelium more susceptible to accumulative genetic alter-
ations that affect its overall function and morphology.
Because of its critical role in vision and for the mainte-
nance of photoreceptor function, understanding biological
processes in the RPE are fundamentally important. Condi-
tional gene inactivation studies have been undertaken to
determine RPE-speciﬁc functions of certain genes. Several
transgenic mouse strains have been developed that express
Cre recombinase (Cre) in the RPE driven by a gene promoter
that is active in this epithelium. These mice allow targeted
inactivation of a gene in the RPEwhen crossed with mice that
carry ﬂoxed alleles for the gene of interest.2e7 Moststigative Pathology.
.RPE-speciﬁc Cre strains that have been reported show an
incomplete Cre expression pattern in the RPE, with patches
of Cre-positive RPE cells adjacent to Cre-negative RPE cells.
Thus, it is important to correlate phenotypic changes in the
RPE with the Cre expression pattern. Furthermore, the extent
of Cre expression is variable, and it has been reported that
mice of the same transgenic strain show a high degree of
variability of Cre expression, with the observation of com-
plete silencing of Cre expression in some mice that carry the
Cre allele.2 Cre-mediated RPE toxicity has been reported in
Trp1-Cre transgenic mice,3,8 raising the question whether
this is a strain-speciﬁc observation or whether Cre expression
in the RPE results in toxicity as a general phenomenon that
may depend on the level and duration of cellular Cre
Cre-Mediated RPE Abnormalitiesexpression in the RPE. The Trp1-Cre strain shows RPE-
speciﬁc Cre expression already at embryonic day 10.5,
which suggests that RPE-speciﬁc abnormalities in these mice
may result from developmental abnormalities due to Cre
expression at the onset of RPE morphogenesis. Whether Cre
expression in the RPE postnatally would affect its viability
and function is not known.
In several other cell types Cre-mediated cell toxicity has
been reported, with degenerative changes that correlated to
the degree of Cre expression.9e11 This Cre toxicity may
result from genetic alterations due to sequences in the
genome that may be targeted by Cre. Cre catalyzes recom-
bination between two loxP recognition sites, which is
characterized by a short recognition sequence.12,13 Reports
have shown that Cre expression can lead to DNA cleavage
in mammalian cells at sites with homology to the loxP
recognition sites (pseudo-loxP sites), which results in ge-
netic alterations in mammalian cells that can signiﬁcantly
affect cell function.14,15
It is likely that the RPE is particularly susceptible to Cre-
mediated toxicity, because it is a nonregenerative epithelium
that would accumulate genetic changes with progressive
age. To test this hypothesis, VMD2-Cre mice (also named
BEST1-Cre mice) that express Cre in the RPE after post-
natal day 10 were examined for Cre-mediated RPE abnor-
malities.2 If Cre expression by itself leads to phenotypic
changes in the RPE, we hypothesized that these changes
would increase with progressive age and the amount of Cre
expression in the RPE. Indeed, we show that RPE abnor-
malities in VMD2-Cre mice progressed with age and were
more pronounced in mice that were homozygous for the Cre
allele than in heterozygous mice. These ﬁndings have
important implications for conditional inactivation studies in
the RPE, and they suggest that the RPE is susceptible to
Cre-mediated cellular dysfunction. Phenotypes due to RPE-
speciﬁc conditional inactivation of a target gene need to be
interpreted in the context of Cre-mediated cellular abnor-
malities, and in all studies mice heterozygous for Cre with
age-matched heterozygous Cre control mice should be used.
The conclusions that can be made in RPE-speciﬁc gene
inactivation studies that use these mice, and likely with
other RPE-speciﬁc Cre strains as well, need to carefully
consider the observed variability of RPE abnormalities even
among Cre heterozygous mice.
Materials and Methods
Animals
The generation of VMD2-Cre mice (BEST1-Cre mice) was
previously reported.2 These mice were maintained on the
original background and crossed with either C57BL/6J or
VMD2-Cre mice to generate either homozygous or hetero-
zygous VMD2-Cre mice. The rd1 and rd8 mutation was
excluded in these mice. Mice heterozygous and homozygous
for VMD2-Cre and control littermates were compared up toThe American Journal of Pathology - ajp.amjpathol.org13 months of age. Experimental groups of mice at ages 1, 4,
or 7 months of age were used for quantitative analyses (nZ 3
mice per group). In addition, aged wild-type C57BL/6J mice
up to 20 months of age were examined. For all animal studies
institutional approval by Massachusetts General Hospital
was granted. Zygosity for Cre was determined by real-time
quantitative PCR (Real Time Laboratories, Carrollton, TX).
Immunolabeling, Microscopy, and Quantiﬁcation of
RPE Abnormalities
Eyes were enucleated and ﬁxed in 4% paraformaldehyde
overnight at 4C or for shorter durations at room temperature.
The observed RPE abnormalities occurred independently of
the ﬁxation protocol. Because Cre expression occurs in
patches in VMD2-Cre mice, Cre-negative RPE cells served
as an internal control for the observed abnormalities and the
immunolabeling experiments. In addition, for each experi-
mental mouse group littermate wild-type mice were used as
controls. Eyes were dissected along the ora serrata to remove
the anterior chamber, iris, and lens. The retina was removed,
and the remaining posterior eyecup (choroid/RPE tissue) was
used for subsequent analysis. For choroidal ﬂat mount
staining, posterior eyecups (choroid/RPE tissue without
retina) were permeabilized in 0.5% Triton X and subse-
quently blocked with 5% goat serum. Primary antibodies
were incubated overnight at 4C. The following primary
antibodies were used: mouse anti-Cre (clone 2D8; Millipore,
Billerica, MA), monoclonal anti-mouse non-phospho
(active) b-catenin (Ser33/37/Thr41; D13A1; Cell Signaling
Technology Inc, Danvers, MA), and Alexa 488-conjugated
phalloidin (Life Technologies). Secondary antibodies used
were Alexa 555 or Alexa 647 (Life Technologies, Carlsbad,
CA). Colabeling experiments as well as single-labeling ex-
periments were performed, and experiments that omitted
either the primary or the secondary antibodies were used to
distinguish immunolabeling from autoﬂuorescence. Nuclei
were labeled with DAPI (Life Technologies). After immu-
nolabeling posterior eyecups were ﬂat mounted on cover
slides with four radial incisions, and Prolong Gold mounting
mediumwas used (Life Technologies). Images were acquired
with a Nikon Eclipse confocal microscope (Nikon, Melville,
NJ) or a Zeiss Axiovert epiﬂuorescence microscope (Carl
Zeiss, Thornwood, NY) at 10 and 20 magniﬁcation.
At least ﬁve images of choroidal ﬂat mounts were acquired
from each eye to cover the entire fundus. From representative
microscopic images taken at 20 magniﬁcation, 20 Cre-
positive and Cre-negative RPE cells were randomly selected
and analyzed for cell size and cytoplasmic active b-catenin
immunolabeling intensity. Cell size was determined by out-
lining cell membranes of RPE cells by using Axiovision soft-
ware version 4.8.2. Average cell size per mouse was measured,
and statistically signiﬁcant differences in each experimental
group were determined with a two-tailed Student’s t-test.
A scoring system was established to determine cyto-
plasmic active b-catenin levels. Normal cytoplasmic active1661
Figure 1 Cre expression in the RPE correlates
with abnormal RPE cell morphology and attenuation
of cytoplasmic b-catenin and phalloidin staining in
VMD2-Creþ/WT mice. A: Immunolabeling of a
choroidal ﬂat mount in a 13-month-old VMD2-Creþ/WT
mouse shows that Cre-expressing (Creþ/WT) cells
(long arrow) are smaller and have attenuated cyto-
plasmic active b-catenin labeling, compared with
adjacent Cre-negative cells (short arrow). B: Cre-
expressing (Creþ/WT) (long arrow) cells also show
reduced phalloidin labeling compared with Cre-
negative cells (short arrow) in the same choroidal
ﬂat mount. C and D: Smaller magniﬁcation images
from same choroidal ﬂat mount indicate that Cre
expression in RPE cells is associated with reduced
phalloidin and cytoplasmic active b-catenin staining
and with smaller RPE cell size (long arrows),
compared with Cre-negative RPE cells (short arrows).
E: Choroidal ﬂat mount staining for active b-catenin,
phalloidin, and Cre in a 13-month-old wild-type (Cre-
negative) age-matched littermate shows normal RPE
cells. F: In a 13-month-old VMD2-Creþ/WT mouse with
silenced Cre expression in the RPE (no Cre expression
was detected by immunolabeling for Cre), no RPE
abnormalities were found, indicating that RPE ab-
normalities correlate with Cre expression in this
mouse strain. Blue nuclei are because of DAPI stain-
ing. Scale bars: 50 mm (A and B); 100 mm (CeF).
He et alb-catenin levels as seen in Cre-negative RPE cells were
scored 3.0, whereas reduced staining for cytoplasmic active
b-catenin was scored 2.0, and absence of cytoplasmic active
b-catenin labeling was scored 1.0. Statistically signiﬁcant
differences in each experimental group were determined
with a two-tailed Student’s t-test. P values < 0.05 were
considered statistically signiﬁcant.
Results
Progressive Age-Dependent Abnormalities in the RPE
in Heterozygous VMD2-Cre Mice
We hypothesized that continuous chronic exposure of RPE
cells to Cre would result in cellular abnormalities and would1662thus increase with progressive age. Therefore, we examined
whether heterozygous VMD2-Cre mice showed abnormal-
ities of the RPE with progressive age. We found that a sen-
sitive method to analyze morphological abnormalities in the
RPE was by labeling posterior eyecups (after removing the
retina) with ﬂuorescein-labeled phalloidin, which labeled the
actin cytoskeleton of cells and highlighted the cell mem-
branes of RPE cells. Fluorescein-phalloidin labeling showed
regular honeycomb pattern morphology of RPE cells and
uniform cytoplasmic labeling in control mice. In the labeling
experiments of posterior eyecups we also included immu-
nolabeling for active b-catenin, which showed strong stain-
ing of the RPE cell membranes (because b-catenin is a
component of the adherens junctions of RPE cells) and in
addition uniform labeling of the cytoplasm. Progressiveajp.amjpathol.org - The American Journal of Pathology
Figure 2 Progressive age-dependent RPE abnor-
malities in heterozygous VMD2-Cre mice (Creþ/WT). A:
Quantitative analysis shows that RPE cell size of Cre-
expressing (Creþ/WT; gray bars) cells compared with
Cre-negative (black bars) cells is unchanged in 1-
month-old heterozygous VMD2-Cre mice (het),
whereas Cre-expressing (Creþ/WT) RPE cells in 4- and
7-month-old heterozygous VMD2-Cre mice show a
signiﬁcant reduction in cell size. B: Scoring cyto-
plasmic active b-catenin labeling in Cre-expressing
(Creþ/WT) and Cre-negative RPE cells reveals a signif-
icant attenuationof cytoplasmic activeb-cateninwith
progressive age in heterozygous VMD2-Cre mice. C:
One-month-old heterozygous VMD2-Cre mice show
Cre-expressing (Creþ/WT) RPE cells with normal cell
morphology and normal cytoplasmic active b-catenin
staining (long arrow), compared with adjacent Cre-
negative RPE cells (short arrow). D: A representative
image of a choroidal ﬂat mount from a 7-month-old
heterozygous VMD2-Cre mouse (Creþ/WT). Although
Cre-negative cells show normal cell size and honey-
comb morphology with uniform cytoplasmic active b-
catenin staining, Cre-expressing (Creþ/WT) cells show
loss of cytoplasmic active b-catenin staining and
atypically formed small RPE cells (white arrow).
Notably, some Cre-expressing (Creþ/WT) cells appear
normal (black arrow). A subset of Cre-expressing
(Creþ/WT) cells show a displacement of cell nuclei to-
ward the periphery, opposed to the normal central or
paracentral localization of RPE cell nuclei (yellow
short arrows). Although normal RPE cells show one or
two cell nuclei, few Cre-expressing (Creþ/WT) cells
show three nuclei (short white arrow). E and F:
Phalloidin labeling of the ﬂat mounts shown in
C and D. Although 1-month-old heterozygous VMD2-
Cre mice show normal phalloidin labeling of Cre-
expressing (Creþ/WT) cells (E, long arrow) as seen in
adjacent Cre-negative cells (E, short arrow), 7-
month-old heterozygous VMD2-Cre mice show loss of
phalloidin labeling in Cre-expressing (Creþ/WT) cells,
while adjacent Cre-negative RPE cells show normal
phalloidin labeling (arrows as in D). G and H: Age-
matched 1- or 7-month-old wild-type control mice
do not show these RPE abnormalities and instead
reveal a uniform labeling pattern for phalloidin (lower
part of images) and cytoplasmic active b-catenin
(upper part of images), which is maintained with
increasing age of the mice. Data are expressed as
means  SD. n Z 3 mice per group (A and B).
*P< 0.05, **P< 0.01, and ***P< 0.001. Scale bars:
100 mm.
Cre-Mediated RPE Abnormalitiesaging did not affect the regular RPE cell morphology, phal-
loidin staining, and active b-catenin labeling (control mice up
to 20 months old were examined) (Figure 1E).
We used posterior eyecups from groups of heterozygous
VMD2-Cre mice that were 1, 4, 7, or 13 months old for
phalloidin and active b-catenin labeling. To correlate
morphological changes of RPE cells with Cre expression,
we included immunolabeling for Cre in these experiments
(strongly labeling Cre-positive nuclei in VMD2-Cre mice).
These VMD2-Cre mice show Cre expression at approxi-
mately postnatal day 10; thus, RPE cells of 1-month-old
VMD2-Cre mice were exposed to Cre only for a few weeks. InThe American Journal of Pathology - ajp.amjpathol.orgthese 1-month-old heterozygous VMD2-Cre mice (Creþ/WT)
we did not observe signiﬁcant changes in RPE cell
morphology, and phalloidin and active b-catenin labeling were
not signiﬁcantly reduced compared with adjacent Cre-negative
cells (or age-matched control mice) (Figure 2, AeC, E, and G).
However, in heterozygousVMD2-Cremice that were 4 or 7
months old, Cre-positive (CreWT/þ) RPE cells showed
signiﬁcantly altered cell morphology with a progressive
age-dependent reduction of cell size, reduced phalloidin la-
beling, and diminished cytoplasmic active b-catenin labeling
(Figure 2, A, B, D, and F). Loss of cytoplasmic active
b-catenin labeling was the ﬁrst observed change and the most1663
Figure 3 RPE abnormalities increase in homo-
zygous VMD2-Cre (Creþ/þ) mice. A and B: Like
heterozygous VMD2-Cre mice (het), 1-month-old
homozygous VMD2 Cre mice (hom) show no statis-
tically signiﬁcant reduction in cell size or cyto-
plasmic active b-catenin labeling. However,
4-month-old homozygous VMD2-Cre mice show a
signiﬁcantly reduced cell size and loss of cyto-
plasmic active b-catenin labeling, seen as well in
4-month-old heterozygous VMD2-Cre mice. C: Cre
expression in 1-month-old homozygous VMD2-Cre
(Creþ/þ) mice does not cause marked morpholog-
ical RPE abnormalities and shows normal active
b-catenin staining (long arrow points to an RPE cell
with normal appearance and cytoplasmic active
b-catenin labeling), compared with adjacent Cre-
negative RPE cells (short arrow). D: Four-month-
old control wild-type mouse shows normal active
b-catenin staining and RPE cell size. E: In 4-month-
old heterozygous VMD2-Cre mice (CreWT/þ) RPE cells
that stain for Cre often show reduced cell size and
staining for active b-catenin (long arrow), whereas
Cre-negative cells appear normal (short arrow). F:
Four-month-old homozygous VMD2-Cre mice
(Creþ/þ) show highly irregular Cre-expressing RPE
cells with variable cell size. Some Cre-expressing
(Creþ/þ) RPE cells show loss of cytoplasmic active
b-catenin labeling (long arrow), and some Creþ/þ
RPE cells show an increased number of cell nuclei
with irregular size and form (short arrow). Data are
expressed as means  SD, nZ 3 mice per group (A
and B). *P < 0.05, **P < 0.01, and ***P < 0.001.
Scale bars: 100 mm.
He et alsensitive method to determine Cre-induced RPE abnormal-
ities, and it was used to quantitate age-dependent Cre-mediated
cell abnormalities (Figure 2B). In contrast to 1-month-old
heterozygous VMD2-Cre mice that showed normal labeling
for cytoplasmic active b-catenin, 4- and 7-month-old mice
showed a highly signiﬁcant and progressive loss of cyto-
plasmic active b-catenin labeling in Cre-positive (CreWT/þ)
cells compared with Cre-negative cells. In age-matched
control mice no abnormalities of RPE cell morphology,
phalloidin labeling, or cytoplasmic active b-catenin labeling
was observed (Figure 2, G and H). Consistent with normal
electroretinograms in these mice, no major morphological
photoreceptor abnormalities were detected (not shown).2
Importantly, some Cre-expressing (CreWT/þ) RPE cells
showednormal cellmorphologyandphalloidin andcytoplasmic
active b-catenin labeling, indicating a degree of variability of
RPE cell abnormalities in VMD2-Cre mice (Figure 2, D and F).
Notably, in a subset of Cre-expressing (CreWT/þ) RPE cells in 7-
month-old VMD2-Cre mice we observed atypical nuclei
(Figure 2F). Although normal RPE cells show either one or two
nuclei that are located in a central or paracentral position within1664RPE cells, some Cre-expressing (CreWT/þ) RPE cells showed
either three nuclei or an atypical localization of nuclei closer
toward the cell membranes (Figure 2, D and F).
The observed changes in heterozygous VMD2-Cre mice
became even more apparent with advanced age. Choroidal
ﬂat mount staining in 13-month-old heterozygous VMD2-
Cre mice consistently showed that Cre-expressing
(CreWT/þ) RPE cells, compared with Cre-negative RPE
cells, have a smaller cell size and showed weaker staining
for phalloidin and active b-catenin (Figure 1, AeD). These
changes were not observed in eyes from control wild-type
littermate mice or VMD2-Cre heterozygous mice with
silenced Cre expression (no Cre-labeling was observed)
(Figure 1, E and F), further conﬁrming that the observed
abnormalities are due to cellular Cre expression in the RPE.
Homozygosity for Cre Results in Highly Irregular RPE
Cell Nuclei
Our observation that cellular abnormalities of the RPE in
heterozygous VMD2-Cre mice increase with age suggestedajp.amjpathol.org - The American Journal of Pathology
Figure 4 Nuclear RPE abnormalities increase in
homozygous VMD2-Cre (Creþ/þ) mice. AeD: Higher
magniﬁcation images of RPE cells from a 4-month-
old homozygous VMD2-Cre mouse (Creþ/þ). A:
Increased numbers of cell nuclei in Cre-expressing
Creþ/þ RPE cells (short white arrow) are observed
much more frequently than in aged heterozygous
VMD2-Cre mice, and some cells have more than three
nuclei (long white arrow) (which was not observed
in heterozygous VMD2-Cre mice). Creþ/þ cell nuclei
are often atypically displaced in a peripheral intra-
cellular localization (yellow arrow). B: Some Creþ/þ
RPE cells in 4-month-old homozygous VMD2-Cre
mice show a large number of cell nuclei with highly
variable size and form (white arrow). C: Atypical
forms of Creþ/þ nuclei are observed in RPE cells of
these homozygous VMD2-Cre mice, some appearing
as ring-like nuclei (white arrow). D: DAPI staining
binds to DNA and labels nuclei. In irregular RPE cells
with an increased number of Cre-expressing Creþ/þ
cell nuclei (short yellow arrows) additional DAPIþ
nuclei that were negative for Cre (long yellow
arrow) are observed. E: In age-matched 4-month-old
heterozygous VMD2-Cre mice (CreWT/þ) only a few
cells show more than two nuclei or other nuclear
abnormalities (arrow). F: These nuclear changes are
not observed in wild-type control mice of the same
age. Scale bars: 50 mm.
Cre-Mediated RPE Abnormalitiesthat long-term expression of Cre results in progressive
accumulation of cytopathic effects. This suggests that the
amount and duration of Cre expression was directly corre-
lated to the RPE abnormalities in VMD2-Cre mice. Thus,
we speculated that mice that are homozygous for VMD2-
Cre (VMD2-Creþ/þ) should manifest RPE abnormalities
earlier or with a higher degree of severity than age-matched
heterozygous VMD2-Cre (VMD2-Creþ/WT) mice.
We used posterior eyecups of 1- and 4-month-old ho-
mozygous VMD2-Cre mice and compared them directly to
age-matched heterozygous and control mice in our labeling
experiments for phalloidin, Cre, and active b-catenin
(Figure 3, AeF). As with heterozygous VMD2-Cre mice,
Cre-positive RPE cells in 1-month-old homozygous VMD2-
Cre mice did not show a signiﬁcant reduction of RPE cell
size or cytoplasmic active b-catenin labeling compared with
Cre-negative RPE cells (Figure 3, AeC). However, simi-
larly to heterozygous VMD2-Cre mice, 4-month-old ho-
mozygous VMD2-Cre mice showed signiﬁcantly reduced
cell size and cytoplasmic active b-catenin labeling ofThe American Journal of Pathology - ajp.amjpathol.orgCre-positive RPE cells compared with Cre-negative RPE
cells (Figure 3, A and B). Notably, cell size and cytoplasmic
active b-catenin labeling was not signiﬁcantly different in
Cre-positive RPE cells between heterozygous or homozy-
gous VMD2-Cre mice (P > 0.05), indicating that the
presence of a single Cre allele is already sufﬁcient to reduce
RPE cell size and cytoplasmic active b-catenin. Importantly,
although only a few nuclei in Cre-expressing (CreWT/þ)
RPE cells appeared abnormal in number, shape, or intra-
cellular localization in 4- or 7-month-old heterozygous
VMD2-Cre mice (Figures 2D and 3E), 3- or 4-month-old
homozygous mice already showed highly increased RPE
cell nuclear abnormalities (Figures 3F and 4, AeD).
Although no more than three nuclei were observed in 4- or
7-month-old heterozygous Creþ RPE cells (Figures 2D and
4E), Cre-expressing (Creþ/þ) RPE cells in 4-month-old
homozygous VMD2-Cre mice showed often more than
three nuclei with highly irregular size, shape, and intracel-
lular distribution (Figure 4, AeD). Some RPE cells in ho-
mozygous VMD2-Cre mice showed ring-like structured1665
He et alnuclei that stained for Cre (Figure 4C) or several Cre-
negative DAPI-labeled nuclei within the same cell that
contained Cre-positive DAPI-labeled nuclei (Figure 4D).
These highly irregular nuclear abnormalities were
observed in young (3 to 4 months old) homozygous VMD2-
Cre mice (Creþ/þ) but not even in 13-month-old heterozy-
gous VMD2-Cre mice (Figure 1, AeD), suggesting that
increased Cre-gene dosage in homozygous mice causes
more severe nuclear abnormalities in the RPE. Four-month-
old heterozygous VMD2-Cre mice showed only a few nu-
clear abnormalities with some RPE cells having three nuclei
(Figure 4E), whereas these nuclear abnormalities were not
observed in wild-type control mice (Figure 4F).Discussion
Expression of Cre in the RPE in VMD2-Cre mice results in
age-dependent progressive abnormalities of the RPE, and
nuclear abnormalities are more pronounced in mice that are
homozygous for the Cre allele than in heterozygousmice. This
observation is consistent with a role of Cre in inducing cellular
abnormalities in the RPE that depend on the amount of Cre and
the duration of exposure of the cell to this recombination-
catalyzing enzyme. Similarly, severe morphological abnor-
malities in RPE cells have been reported for Trp1-Cre mice
that express Cre in the RPE from embryonic day 10.5 on.3,8
In VMD2-Cre mice Cre expression occurs postnatally
(approximately postnatal day 10), whereas in Trp1-Cre mice
Cre expression has been reported to start at approximately
embryonic day 10.5, which may explain the less severe Cre-
mediated RPE abnormalities in heterozygous VMD2-Cre
mice compared with those observed in Trp1-Cre mice. The
occurrence of RPE defects in both Trp1-Cre mice and
VMD2-Cre mice, and the increasing RPE abnormalities
with age and Cre gene dosage in VMD2-Cre mice, suggests
that these RPE abnormalities are a direct consequence of the
amount and duration of Cre expression in the RPE and may
be a general phenomenon that is not limited to a single RPE-
speciﬁc Cre strain.
Notably, RPE changes were already noticed in 3- to 4-
month-old mice that were heterozygous for Cre (VMD2-
Creþ/WT mice), and these changes varied among different
mice of the same genotype. This observation indicates that
phenotypes in mice with conditional inactivation of genes in
the RPE by using the Cre/loxP system must be carefully
compared with age-matched heterozygous Cre control mice,
and phenotypic changes must be evaluated in this context.
Overall, the variability of Cre-mediated RPE abnormalities
in VMD2-Cre mice need to be considered when drawing
conclusions from conditional gene targeting studies in the
RPE, particularly when the observed phenotypes are mild or
when analyzing aged mice.
Several studies have investigated Cre-induced cytopathic
effects.9,14,16 For example, Cre expression in basal kerati-
nocytes in mouse epidermis was shown to induce DNA1666damage and tetraploidy in keratinocytes.16 In that same
study it was shown that Cre expression in a chromosomally
stable cell line (HCT116 cells) induced DNA damage,
genomic instability and tetraploidy in vitro. Notably, ho-
mozygosity for Cre in basal keratinocytes (K5Creþ/þ mice)
was associated with an accelerated formation of skin cancer
in a chemical model of skin carcinogenesis.10 The skin
phenotype with abnormal whiskers and hair coat (and
abnormal mammary glands with impaired lactation) was
noticed only in homozygous K5-Cre mice but not in het-
erozygotes. This observation is consistent with a dose-
dependent cytopathic effect of Cre.
Previously, it was shown that Cre toxicity can develop in a
dose-dependent manner and in the absence of loxP target sites.
These Cre-induced abnormalities lead to growth arrest, chro-
mosomal abnormalities, and cell death in vitro.17 Notably,
generation of Cre mutants that lack the ability to cleave DNA
showed no cytotoxic effects in vitro.17 Use of a self-excising
retroviral vector that allowed limiting the duration and in-
tensity of Cre expression resulted also in reduced cell toxicity.17
It has been speculated that Cre causes these cellular ab-
normalities due to recombinations that occur at pseudo-loxP
sites in the mammalian genome and lead to an accumulation
of chromosomal aberrations.11,14,18 Notably, cellular ab-
normalities induced by Cre occur after extended periods of
Cre activity; thus, there seems to be a more pronounced
cytotoxic effect of Cre with increased dose and duration of
Cre exposure.9
These previous studies are consistent with the observation
of Cre-induced abnormalities in RPE cells in VMD2-Cremice,
because this epithelium is a postmitotic nonregenerative
epithelium, and continuous Cre expression in the RPE would
thus be predicted to result in cellular abnormalities in an age-
and gene dosage-dependent manner. Particularly, the obser-
vation of highly irregular RPE cell nuclei in homozygous
VMD2-Cre mice suggests that one mechanism through which
Cre induces cytopathic changes in the RPE of these mice may
indeed be by causing DNA damage and polyploidy.
A previous study suggested that short-term exposure to
Cre can signiﬁcantly reduce its cytopathic effects.19 Self-
deleting Cre expression vectors or inducible Cre mouse
strains (eg, tamoxifen or doxycycline-inducible Cre
expression systems) may permit temporal control of Cre
expression that result in recombination at loxP sites, while
limiting the unwanted cytopathic effects of prolonged Cre
expression in mammalian cells.
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